Self-monitoring of blood glucose (SMBG)

BEHAVIORAL3 trials

Sponsors

Medical Research Foundation, The Netherlands, The Third Xiangya Hospital of Central South University, Bionime Corporation

Conditions

Diabetes (DM)Diabetes Mellitus, Type 2Type 2 Diabetes Mellitus (T2DM)

Phase 3

Effect of Self-monitoring of Blood Glucose in Patients With Type 2 Diabetes Mellitus Not Using Insulin

CompletedNCT00287807

Medical Research Foundation, The NetherlandsDiabetes Mellitus, Type 2

Start: 2006-02-28End: 2008-10-31Target: 60Updated: 2011-09-26

Unknown Phase

DP-DCT 1.0：A Comparative Clinical Study on the Effect of Dapagliflozin Combined With CGM Versus SMBG on Glycemic Control in Patients With Type 2 Diabetes Mellitus Based on the DP-DCT Platform

Not yet recruitingNCT07595289

The Third Xiangya Hospital of Central South UniversityType 2 Diabetes Mellitus (T2DM)

Start: 2026-08-01End: 2027-08-01Target: 120Updated: 2026-05-19

RIGHTEST iFree 2 CGM System for Glycemic Control in Adults With Diabetes Mellitus

RecruitingNCT07889375

Bionime CorporationDiabetes (DM)

Start: 2026-05-15End: 2027-03-31Target: 324Updated: 2026-10-26

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01